Survey of Public Knowledge and perceptions about clinical research in Mumbai
Not Applicable
- Registration Number
- CTRI/2015/10/006259
- Lead Sponsor
- Sethgsmcandkemh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 1200
Inclusion Criteria
We will select all adult participants from mumbai in this study who are willing to give informed consent for participation in the study
Exclusion Criteria
below18yearsofageandpeoplewhoarenotresidentsofmumbai
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the gaps in awareness about clinical research and extent of misinformation amongst people of mumbai regarding clinical researchTimepoint: we will evaluate the response only once at the time of administration of the questionnaire
- Secondary Outcome Measures
Name Time Method to aid in taking appropriat e steps for improving public awareness about clinical research amongst the general public of mumbaiTimepoint: 24 months from the date of ethics committee approval
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does public perception in Mumbai influence enrollment in clinical trials targeting BRCA-mutated breast cancer?
What biomarkers are most commonly discussed in Mumbai-based clinical research awareness campaigns?
How does the CTRI/2015/10/006259 trial compare to global studies on public understanding of PD-1/PD-L1 inhibitor therapies?
What adverse event communication strategies improve trust in Mumbai's clinical trial landscape?
How does the Sethgsmcandkemh trial's findings correlate with adoption rates of CRISPR-based therapies in India?